title: [Current chemotherapeutic trends in the treatment of malignant lymphomas with special reference to Hodgkin's disease].
abstract: Sequential or simulatineous use is made of four types of antiproliferative drugs in the modern treatment of malignant lymphoma: alkylating drugs, including procarbazine; Vinca rosea alkaloids; antibiotics; corticosteroids. The simulataneous employment of two or more drugs appears to give best results, though it cannot eradicate the disease; this is possible with radiation or surgery in the early stages. Chemotherapy is nevertheless without alternative in the more advanced stages. Long periods of even complete remission may thus be achieved.
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D011859:Radiography
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Attuali orientamenti chemioterapici nel trattamento dei linfomi maligni con particolare riguardo al morbo di Hodgkin